Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)
China flag China · Delayed Price · Currency is CNY
20.44
-1.36 (-6.24%)
At close: Aug 24, 2026

SHE:001367 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
140.82135.88122.56104.67107.5994
Depreciation & Amortization
27.323.1816.7913.4114.313.03
Other Amortization
0.720.850.491.991.681.71
Loss (Gain) From Sale of Assets
---0.24--
Asset Writedown & Restructuring Costs
-1.280.41.230.961.210.67
Loss (Gain) From Sale of Investments
-8.19-6.71-3-0.323.85-1.45
Provision & Write-off of Bad Debts
2.32.730.090.431.09-0.27
Other Operating Activities
4.181.120.61.6-7.454.29
Change in Accounts Receivable
-15.98-16.48-27.23-20.5611.11-22.35
Change in Inventory
-1.88-3.0537.64-19.1-38.88-20.63
Change in Accounts Payable
1.8517.1711.19-4.6-19.2936.22
Change in Other Net Operating Assets
27.0520.715.77-0.080.22-0.24
Operating Cash Flow
178.59177.45167.1680.6274.95107.04
Operating Cash Flow Growth
7.37%6.16%107.35%7.56%-29.98%39.93%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Capital Expenditures
-52.71-152.26-64.75-57.44-20.19-33.32
Sale of Property, Plant & Equipment
---0.12-0
Investment in Securities
-121.81-144.9830.32-0.99-1.21
Investing Cash Flow
-174.52-297.25-61.75-57-21.18-34.52

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Long-Term Debt Repaid
--1.72-1.86-1.04-1.15-0.88
Total Debt Repaid
-1.72-1.72-1.86-1.04-1.15-0.88
Net Debt Issued (Repaid)
-1.72-1.72-1.86-1.04-1.15-0.88
Issuance of Common Stock
3.583.5825.46698.45--
Common Dividends Paid
-17.67-17.45-34--0.71-16.43
Other Financing Activities
-0.09---24.08-1.9-1.4
Financing Cash Flow
-15.9-15.59-10.39673.33-3.77-18.71

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Foreign Exchange Rate Adjustments
-0.990.912.680.615.52-1.46
Net Cash Flow
-12.83-134.4797.69697.5555.5252.35

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
125.8825.19102.4123.1754.7673.72
Free Cash Flow Growth
1244.19%-75.40%341.91%-57.68%-25.73%32.89%
Free Cash Flow Margin
23.27%4.73%21.72%5.83%12.95%18.95%
Free Cash Flow Per Share
0.820.170.690.170.490.66
Levered Free Cash Flow
67.84-21.283.57-18.14-2.3544.27
Unlevered Free Cash Flow
67.95-20.9883.8-18.12-2.3144.34

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash Income Tax Paid
9.278.9319.2733.385.2412.89
Change in Working Capital
12.7420.0128.39-42.36-47.31-4.94